Cognitive profiles in primary progressive aphasia and its variants

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimer's & Dementia vol. 21 (Dec 1, 2025)
Autor principal: Fernandez‐Romero, Lucia
Otros Autores: Oliver‐Mas, Silvia, Delgado‐Alonso, Cristina, Díez‐Cirarda, María, Valiente‐Gordillo, Esther, López‐Carbonero, Juan Ignacio, Matias‐Guiu, Jorge, Gil‐Moreno, María José, Matias‐Guiu, Jordi A
Publicado:
John Wiley & Sons, Inc.
Materias:
Acceso en línea:Citation/Abstract
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3286458956
003 UK-CbPIL
022 |a 1552-5260 
022 |a 1552-5279 
024 7 |a 10.1002/alz70857_099014  |2 doi 
035 |a 3286458956 
045 0 |b d20251201 
100 1 |a Fernandez‐Romero, Lucia  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
245 1 |a Cognitive profiles in primary progressive aphasia and its variants 
260 |b John Wiley & Sons, Inc.  |c Dec 1, 2025 
513 |a Journal Article 
520 3 |a Background Primary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by the progressive impairment of language abilities. However, recent findings suggest that other cognitive domains, beyond language, may also be affected in the early stages of the disease. Exploring cognitive domains could facilitate the diagnosis of PPA and its classification into the three main variants (non‐fluent (nfvPPA), semantic (svPPA) and logopenic (lvPPA)), which remains challenging. This study aimed to identify non‐linguistic cognitive alterations in PPA and its variants. Method A cross‐sectional study including 157 patients with PPA and 74 cognitively unimpaired controls. Patients were classified into nfvPPA (N = 58), svPPA (N = 19), and lvPPA (N = 80) using a language battery, FDG‐PET, and CSF biomarkers. The mean age was 69,97 ± 8.12 years, and the 61.04% were females. Four cognitive domains (attention and working memory, executive functions, episodic memory and visuospatial abilities) were assessed using the ACE‐III and the following cognitive tests: Digit Span, TMT‐A and B, Rey‐Osterrieth Complex Figure (copy and 3‐minute recall), VOSP and Tower of London. Result All PPA variants scored significantly worse than the control group across most explored domains. The lvPPA and svPPA groups scored lower on episodic memory compared to the nfvPPA group. The lvPPA group performed worse on visuospatial abilities and executive function than the svPPA group. The nfvPPA group scored lower on attention and working memory tasks compared to the svPPA group. Conclusion This study highlights the impairment of non‐linguistic cognitive domains in PPA and its variants, identifying distinct cognitive profiles across variants that may aid in the patient diagnosis, classification, and monitoring of disease progression. 
653 |a Diagnostic tests 
653 |a Episodic memory 
653 |a Classification 
653 |a Medical diagnosis 
653 |a Aphasia 
653 |a Cognition 
653 |a Recall 
653 |a Language disorders 
653 |a Semantics 
653 |a Ability 
653 |a Variants 
653 |a Executive function 
653 |a Short term memory 
653 |a Disease 
653 |a Biological markers 
653 |a Attention 
653 |a Memory 
653 |a Patients 
653 |a Groups 
653 |a Visual memory 
653 |a Spatial memory 
653 |a Visual-Spatial ability 
700 1 |a Oliver‐Mas, Silvia  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Delgado‐Alonso, Cristina  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Díez‐Cirarda, María  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Valiente‐Gordillo, Esther  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a López‐Carbonero, Juan Ignacio  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Matias‐Guiu, Jorge  |u Hospital Clinico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Gil‐Moreno, María José  |u Hospital Clínico San Carlos, Madrid, Madrid, Spain, 
700 1 |a Matias‐Guiu, Jordi A  |u Hospital Clinico Universitario San Carlos, Madrid, Madrid, Spain, 
773 0 |t Alzheimer's & Dementia  |g vol. 21 (Dec 1, 2025) 
786 0 |d ProQuest  |t Consumer Health Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3286458956/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3286458956/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch